Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL225726 | 0.79 | ALDH1A1 (0.33) | ALDH1A1HSD17B10 | |
| SCHEMBL27687887 | 0.73 | — | — | |
| SCHEMBL1536273 | 0.73 | ALDH1A1 (0.30) | ALDH1A1HSD17B10 | |
| SCHEMBL2387967 | 0.72 | ALDH1A1 (0.33) | ALDH1A1HSD17B10 | |
| SCHEMBL2810230 | 0.72 | ALDH1A1 (0.33) | ALDH1A1HSD17B10 | |
| SCHEMBL2813250 | 0.72 | ALDH1A1 (0.33) | ALDH1A1HSD17B10 | |
| SCHEMBL8076123 | 0.69 | ALDH1A1 (0.32) | ALDH1A1HSD17B10 | |
| SCHEMBL10376271 | 0.67 | LMNA (0.33) | ALDH1A1HSD17B10 | |
| SCHEMBL339702 | 0.65 | — | — | |
| SCHEMBL28941 | 0.65 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 25 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3995478-A1 | METHOD FOR PRODUCING ALKANE | Daikin Industries, Ltd. (JP) | 2022-05-11 | — | — | EP | claimed |
| EP-3995479-A1 | ALKANE PRODUCTION METHOD | Daikin Industries, Ltd. (JP) | 2022-05-11 | — | — | EP | claimed |
| US-20220119327-A1 | ALKANE PRODUCTION METHOD | DAIKIN INDUSTRIES, LTD. (JP) | 2022-04-21 | — | — | US | claimed |
| US-20220119325-A1 | METHOD FOR PRODUCING ALKANE | DAIKIN INDUSTRIES, LTD. (JP) | 2022-04-21 | — | — | US | claimed |
| CN-114080377-A | Process for producing alkane | 大金工业株式会社 | 2022-02-22 | — | — | CN | claimed |
| CN-114040903-A | Process for producing alkane | 大金工业株式会社 | 2022-02-11 | — | — | CN | claimed |
| WO-2021002343-A1 | ALKANE PRODUCTION METHOD | ダイキン工業株式会社 | 2021-01-07 | — | — | WO | claimed |
| WO-2021002344-A1 | METHOD FOR PRODUCING ALKANE | ダイキン工業株式会社 | 2021-01-07 | — | — | WO | claimed |
| US-20080108749-A1 | Fluoropolymer nanoemulsions | NANOMAX TECHNOLOGY COMPANY LIMITED | 2008-05-08 | — | — | US | claimed |
| CN-119081699-A | Process for producing alkane | 大金工业株式会社 | 2024-12-06 | — | — | CN | disclosed |
| CN-114040903-B | Process for producing alkane | 大金工业株式会社 | 2024-10-29 | — | — | CN | disclosed |
| EP-3995478-A1 | METHOD FOR PRODUCING ALKANE | Daikin Industries, Ltd. (JP) | 2022-05-11 | — | — | EP | disclosed |
| EP-3995479-A1 | ALKANE PRODUCTION METHOD | Daikin Industries, Ltd. (JP) | 2022-05-11 | — | — | EP | disclosed |
| US-20220119325-A1 | METHOD FOR PRODUCING ALKANE | DAIKIN INDUSTRIES, LTD. (JP) | 2022-04-21 | — | — | US | disclosed |
| US-8404906-B2 | Process for producing 1,2,3,4-tetrachlorohexafluorobutane | SHOWA DENKO K.K. (JP) | 2013-03-26 | — | — | US | disclosed |
| US-20110112341-A1 | PROCESS FOR PRODUCING 1,2,3,4-TETRACHLOROHEXAFLUOROBUTANE | SHOWADENKO K.K. (JP) | 2011-05-12 | — | — | US | disclosed |
| US-20080108749-A1 | Fluoropolymer nanoemulsions | NANOMAX TECHNOLOGY COMPANY LIMITED | 2008-05-08 | — | — | US | disclosed |
| EP-0128516-B2 | Optical fibre | DAIKIN IND LTD (JP) | 1994-08-24 | — | — | EP | disclosed |
| US-4720166-A | FLUOROPOLYMER | DAIKIN KOGYO CO., LTD. (JP) | 1988-01-19 | — | — | US | disclosed |
| EP-0128516-A1 | Optical fibre | DAIKIN INDUSTRIES, LIMITED (JP) | 1984-12-19 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220119325-A1 | METHOD FOR PRODUCING ALKANE | ALK, CAT, ALKBH3 | ALDH1A1 2763/4885HSD17B10 2100/4885 |
| US-20220119327-A1 | ALKANE PRODUCTION METHOD | ALK, ALKBH3, CBR1 | ALDH1A1 207/4885HSD17B10 325/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.